BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 30651350)

  • 1. Uric acid activates aldose reductase and the polyol pathway for endogenous fructose and fat production causing development of fatty liver in rats.
    Sanchez-Lozada LG; Andres-Hernando A; Garcia-Arroyo FE; Cicerchi C; Li N; Kuwabara M; Roncal-Jimenez CA; Johnson RJ; Lanaspa MA
    J Biol Chem; 2019 Mar; 294(11):4272-4281. PubMed ID: 30651350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated Fructose and Uric Acid Through Aldose Reductase Contribute to Experimental and Human Alcoholic Liver Disease.
    Wang M; Chen WY; Zhang J; Gobejishvili L; Barve SS; McClain CJ; Joshi-Barve S
    Hepatology; 2020 Nov; 72(5):1617-1637. PubMed ID: 32086945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous fructose production and metabolism in the liver contributes to the development of metabolic syndrome.
    Lanaspa MA; Ishimoto T; Li N; Cicerchi C; Orlicky DJ; Ruzycki P; Rivard C; Inaba S; Roncal-Jimenez CA; Bales ES; Diggle CP; Asipu A; Petrash JM; Kosugi T; Maruyama S; Sanchez-Lozada LG; McManaman JL; Bonthron DT; Sautin YY; Johnson RJ
    Nat Commun; 2013; 4():2434. PubMed ID: 24022321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: potential role in fructose-dependent and -independent fatty liver.
    Lanaspa MA; Sanchez-Lozada LG; Choi YJ; Cicerchi C; Kanbay M; Roncal-Jimenez CA; Ishimoto T; Li N; Marek G; Duranay M; Schreiner G; Rodriguez-Iturbe B; Nakagawa T; Kang DH; Sautin YY; Johnson RJ
    J Biol Chem; 2012 Nov; 287(48):40732-44. PubMed ID: 23035112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allopurinol ameliorates high fructose diet induced hepatic steatosis in diabetic rats through modulation of lipid metabolism, inflammation, and ER stress pathway.
    Cho IJ; Oh DH; Yoo J; Hwang YC; Ahn KJ; Chung HY; Jeong SW; Moon JY; Lee SH; Lim SJ; Jeong IK
    Sci Rep; 2021 May; 11(1):9894. PubMed ID: 33972568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uric acid stimulates fructokinase and accelerates fructose metabolism in the development of fatty liver.
    Lanaspa MA; Sanchez-Lozada LG; Cicerchi C; Li N; Roncal-Jimenez CA; Ishimoto T; Le M; Garcia GE; Thomas JB; Rivard CJ; Andres-Hernando A; Hunter B; Schreiner G; Rodriguez-Iturbe B; Sautin YY; Johnson RJ
    PLoS One; 2012; 7(10):e47948. PubMed ID: 23112875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High uric acid induces liver fat accumulation via ROS/JNK/AP-1 signaling.
    Xie D; Zhao H; Lu J; He F; Liu W; Yu W; Wang Q; Hisatome I; Yamamoto T; Koyama H; Cheng J
    Am J Physiol Endocrinol Metab; 2021 Jun; 320(6):E1032-E1043. PubMed ID: 33900847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective role of fructokinase blockade in the pathogenesis of acute kidney injury in mice.
    Andres-Hernando A; Li N; Cicerchi C; Inaba S; Chen W; Roncal-Jimenez C; Le MT; Wempe MF; Milagres T; Ishimoto T; Fini M; Nakagawa T; Johnson RJ; Lanaspa MA
    Nat Commun; 2017 Feb; 8():14181. PubMed ID: 28194018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged fructose feeding and aldose reductase inhibition: effect on the polyol pathway in kidneys of normal rats.
    Bellomo G; Comstock JP; Wen D; Hazelwood RL
    Proc Soc Exp Biol Med; 1987 Dec; 186(3):348-54. PubMed ID: 3122222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rat kidney aldose reductase and aldehyde reductase and polyol production in rat kidney.
    Sato S
    Am J Physiol; 1992 Nov; 263(5 Pt 2):F799-805. PubMed ID: 1443170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mild methylenetetrahydrofolate reductase deficiency accelerates liver triacylglycerol and uric acid accumulation in fructose-fed mice.
    Sun D; Zhang X; Tang C; Zhao Q; Qin Y; Zhang J
    Nutr Res; 2022 Dec; 108():33-42. PubMed ID: 36399975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyol pathway in tissues of spontaneously diabetic Chinese hamsters (Cricetulus griseus) and the effect of an aldose reductase inhibitor, ONO-2235.
    Sekiguchi M; Watanabe K; Eto M; Iwashima Y; Morikawa A; Takahashi M; Ishii K; Makino I
    Comp Biochem Physiol B; 1991; 98(4):637-40. PubMed ID: 1907900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel carboxymethylated mercaptotriazinoindole inhibitor of aldose reductase interferes with the polyol pathway in streptozotocin-induced diabetic rats.
    Soltesova Prnova M; Ballekova J; Gajdosikova A; Gajdosik A; Stefek M
    Physiol Res; 2015; 64(4):587-91. PubMed ID: 26291727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural Aldose Reductase Inhibitor: A Potential Therapeutic Agent for Non-alcoholic Fatty Liver Disease.
    Qiu L; Guo C
    Curr Drug Targets; 2020; 21(6):599-609. PubMed ID: 31589122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of uric acid and lactate production by sodium acetate ameliorates hepatic triglyceride accumulation in fructose-insulin resistant pregnant rats.
    Oyabambi AO; Olaniyi KS; Soladoye AO; Olatunji LA
    Environ Toxicol Pharmacol; 2020 Nov; 80():103452. PubMed ID: 32610186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous fructose production and fructokinase activation mediate renal injury in diabetic nephropathy.
    Lanaspa MA; Ishimoto T; Cicerchi C; Tamura Y; Roncal-Jimenez CA; Chen W; Tanabe K; Andres-Hernando A; Orlicky DJ; Finol E; Inaba S; Li N; Rivard CJ; Kosugi T; Sanchez-Lozada LG; Petrash JM; Sautin YY; Ejaz AA; Kitagawa W; Garcia GE; Bonthron DT; Asipu A; Diggle CP; Rodriguez-Iturbe B; Nakagawa T; Johnson RJ
    J Am Soc Nephrol; 2014 Nov; 25(11):2526-38. PubMed ID: 24876114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel insights into the mechanisms whereby isoflavones protect against fatty liver disease.
    Qiu LX; Chen T
    World J Gastroenterol; 2015 Jan; 21(4):1099-107. PubMed ID: 25632182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fructose and sugar: A major mediator of non-alcoholic fatty liver disease.
    Jensen T; Abdelmalek MF; Sullivan S; Nadeau KJ; Green M; Roncal C; Nakagawa T; Kuwabara M; Sato Y; Kang DH; Tolan DR; Sanchez-Lozada LG; Rosen HR; Lanaspa MA; Diehl AM; Johnson RJ
    J Hepatol; 2018 May; 68(5):1063-1075. PubMed ID: 29408694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hesperetin ameliorates hepatic oxidative stress and inflammation
    Li J; Wang T; Liu P; Yang F; Wang X; Zheng W; Sun W
    Food Funct; 2021 May; 12(9):3898-3918. PubMed ID: 33977953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uric acid induced hepatocytes lipid accumulation through regulation of miR-149-5p/FGF21 axis.
    Chen S; Chen D; Yang H; Wang X; Wang J; Xu C
    BMC Gastroenterol; 2020 Feb; 20(1):39. PubMed ID: 32070295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.